Identification of c-myc-dependent proteins in the medulloblastoma cell line D425Med

Amino Acids

Volumn 42, Issue 6, 2012, Pages 2149-2163

  Azizi, Amedeo A ^a   Li, Lin ^a   Ströbel, Thomas ^b   Chen, Wei Qiang ^a   Slavc, Irene ^a   Lubec, Gert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Brain tumour; c myc; Medulloblastoma; myc

Indexed keywords

CHAPERONE; ENDOPLASMIC RETICULUM PROTEIN 29; GUANIDINOACETATE METHYLTRANSFERASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN B; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C2; MYC PROTEIN; SMALL INTERFERING RNA; STATHMIN; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDULLOBLASTOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEOMICS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

CELL LINE, TUMOR; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GUANIDINOACETATE N-METHYLTRANSFERASE; HEAT-SHOCK PROTEINS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; MEDULLOBLASTOMA; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STATHMIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84862766402     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-011-0953-8     Document Type: Article

References (85)

1. J Ahn M Murphy S Kratowicz A Wang AJ Levine DL George 1999 Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction Oncogene 18 5954 5958 10557083 10.1038/sj.onc.1202986 1:CAS:528: DyaK1MXnt1ygurg%3D
2. N Aldosari SH Bigner PC Burger L Becker JL Kepner HS Friedman RE McLendon 2002 MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group Arch Pathol Lab Med 126 540 544 11958658
3. E Alli JM Yang JM Ford WN Hait 2007 Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells Mol Pharmacol 71 1233 1240 17272681 10.1124/mol.106.029702 1:CAS:528: DC%2BD2sXlslSju7Y%3D
4. E Alli JM Yang WN Hait 2007 Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53 Oncogene 26 1003 1012 16909102 10.1038/sj.onc.1209864 1:CAS:528: DC%2BD2sXhslWhtbw%3D
5. AA Azizi SU Kang A Freilinger M Gruber-Olipitz WQ Chen JW Yang M Hengstschlager I Slavc G Lubec 2008 Mitosis-dependent protein expression in neuroblastoma cell line N1E-115 J Proteome Res 7 3412 3422 18582092 10.1021/pr800149p 1:CAS:528:DC%2BD1cXnvVKksLw%3D
6. IF Bambang S Xu J Zhou M Salto-Tellez SK Sethi D Zhang 2009 Overexpression of endoplasmic reticulum protein 29 regulates mesenchymal-epithelial transition and suppresses xenograft tumor growth of invasive breast cancer cells Lab Invest 89 1229 1242 19770839 10.1038/labinvest.2009.87 1:CAS:528:DC%2BD1MXhtlWlur3N
7. MM Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248 254 942051 10.1016/0003-2697(76)90527-3 1:CAS:528: DyaE28XksVehtrY%3D
8. O Braissant C Bachmann H Henry 2007 Expression and function of AGAT, GAMT and CT1 in the mammalian brain Subcell Biochem 46 67 81 18652072 10.1007/978-1-4020-6486-9-4
9. G Brattsand 2000 Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors Br J Cancer 83 311 318 10917544 10.1054/bjoc.2000.1264 1:CAS:528:DC%2BD3cXlslensrY%3D
10. LC Bullions AJ Levine 1998 The role of beta-catenin in cell adhesion, signal transduction, and cancer Curr Opin Oncol 10 81 87 9466489 10.1097/00001622-199801000-00013 1:CAS:528:DyaK1cXoslaltA%3D%3D
11. CA Chapman DP Waber JH Bernstein SL Pomeroy B LaVally SE Sallan N Tarbell 1995 Neurobehavioral and neurologic outcome in long-term survivors of posterior fossa brain tumors: role of age and perioperative factors J Child Neurol 10 209 212 7642890 10.1177/088307389501000308 1:STN:280:DyaK2MzntVGltA%3D%3D
12. G Chen H Wang TG Gharib CC Huang DG Thomas KA Shedden R Kuick JM Taylor SL Kardia DE Misek TJ Giordano MD Iannettoni MB Orringer SM Hanash DG Beer 2003 Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas Mol Cell Proteomics 2 107 116 12644570 10.1074/mcp.M200055- MCP200 1:CAS:528:DC%2BD3sXivFWnt7w%3D
13. WQ Chen SU Kang G Lubec 2006 Protein profiling by the combination of two independent mass spectrometry techniques Nat Protoc 1 1446 1452 17406433 10.1038/nprot.2006.246 1:CAS:528:DC%2BD28Xht1eitL7I
14. C Cheretis F Dietrich I Chatzistamou K Politi E Angelidou H Kiaris S Mkrtchian H Koutselini 2006 Expression of ERp29, an endoplasmic reticulum secretion factor in basal-cell carcinoma Am J Dermatopathol 28 410 412 17012915 10.1097/01.dad.0000211521.49810.ac
15. H Choi CS Park BG Kim JW Cho JB Park YS Bae DS Bae 2001 Creatine kinase B is a target molecule of reactive oxygen species in cervical cancer Mol Cells 12 412 417 11804344 1:CAS:528:DC%2BD38Xjtlelug%3D%3D
16. KJ Christian MA Lang F Raffalli-Mathieu 2008 Interaction of heterogeneous nuclear ribonucleoprotein C1/C2 with a novel cis-regulatory element within p53 mRNA as a response to cytostatic drug treatment Mol Pharmacol 73 1558 1567 18296503 10.1124/mol.107.042507 1:CAS:528:DC%2BD1cXlsVWgu7Y%3D
17. GF Claassen SR Hann 1999 Myc-mediated transformation: the repression connection Oncogene 18 2925 2933 10378689 10.1038/sj.onc.1202747 1:CAS:528:DyaK1MXjs12qt7c%3D
18. P Das T Puri V Suri MC Sharma BS Sharma C Sarkar 2009 Medulloblastomas: a correlative study of MIB-1 proliferation index along with expression of c-Myc, ERBB2, and anti-apoptotic proteins along with histological typing and clinical outcome Childs Nerv Syst 25 825 835 19444455 10.1007/s00381-009-0884-9
19. M Dennis BJ Spiegler CR Hetherington ML Greenberg 1996 Neuropsychological sequelae of the treatment of children with medulloblastoma J Neurooncol 29 91 101 8817420 10.1007/BF00165522 1:STN:280:DyaK28vhsVeqsA%3D%3D
20. CG Eberhart T Tihan PC Burger 2000 Nuclear localization and mutation of beta-catenin in medulloblastomas J Neuropathol Exp Neurol 59 333 337 10759189 1:CAS:528:DC%2BD3cXisleis7c%3D
21. DW Ellison OE Onilude JC Lindsey ME Lusher CL Weston RE Taylor AD Pearson SC Clifford 2005 Beta-catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee J Clin Oncol 23 7951 7957 16258095 10.1200/JCO.2005.01.5479 1:CAS:528:DC%2BD2MXht1CqsL7P
22. S Fattet C Haberler P Legoix P Varlet A Lellouch-Tubiana S Lair E Manie MA Raquin D Bours S Carpentier E Barillot J Grill F Doz S Puget I Janoueix-Lerosey O Delattre 2009 Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics J Pathol 218 86 94 19197950 10.1002/path.2514 1:CAS:528:DC%2BD1MXls1Ort7g%3D
23. Y Feng ZM Tian MX Wan ZB Zheng 2007 Protein profile of human hepatocarcinoma cell line SMMC-7721: identification and functional analysis World J Gastroenterol 13 2608 2614 17552011 1:CAS:528:DC%2BD2sXns1artbo%3D
24. C Giampietro F Luzzati G Gambarotta P Giacobini E Boda A Fasolo I Perroteau 2005 Stathmin expression modulates migratory properties of GN-11 neurons in vitro Endocrinology 146 1825 1834 15625246 10.1210/en.2004-0972 1:CAS:528:DC%2BD2MXis1yqtb8%3D
25. R Gilbertson C Wickramasinghe R Hernan V Balaji D Hunt D Jones-Wallace J Crolla R Perry J Lunec A Pearson D Ellison 2001 Clinical and molecular stratification of disease risk in medulloblastoma Br J Cancer 85 705 712 11531256 10.1054/bjoc.2001.1987 1:CAS:528:DC%2BD3MXns1yktr0%3D
26. JW Goldwein J Radcliffe J Johnson T Moshang RJ Packer LN Sutton LB Rorke GJ D'Angio 1996 Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma) Int J Radiat Oncol Biol Phys 34 899 904 8598368 10.1016/0360-3016(95)02080-2 1:CAS:528:DyaK28XisVCitrc%3D
27. MA Grotzer MD Hogarty AJ Janss X Liu H Zhao A Eggert LN Sutton LB Rorke GM Brodeur PC Phillips 2001 MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma Clin Cancer Res 7 2425 2433 11489822 1:CAS:528:DC%2BD3MXmsVOmtLs%3D
28. MA Grotzer K von Hoff AO von Bueren T Shalaby W Hartmann M Warmuth-Metz A Emser RD Kortmann J Kuehl T Pietsch S Rutkowski 2007 Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91-implications for investigating childhood medulloblastoma Klin Padiatr 219 312 317 18050040 10.1055/s-2007-985843 1:STN:280:DC%2BD1c%2FgvFyhuw%3D%3D
29. M Gruber-Olipitz T Strobel SU Kang JP John MA Grotzer I Slavc G Lubec 2009 Neurotrophin 3/TrkC-regulated proteins in the human medulloblastoma cell line DAOY Electrophoresis 30 540 549 19156760 10.1002/elps.200800325 1:CAS:528:DC%2BD1MXjsFKitL4%3D
30. WN Hait JM Yang 2006 The individualization of cancer therapy: the unexpected role of p53 Trans Am Clin Climatol Assoc 117 85 101 18528466 (discussion 101)
31. B Haley T Paunesku M Protic GE Woloschak 2009 Response of heterogeneous ribonuclear proteins (hnRNP) to ionising radiation and their involvement in DNA damage repair Int J Radiat Biol 85 643 655 19579069 10.1080/09553000903009548 1:CAS:528:DC%2BD1MXptFOjtb8%3D
32. SR Hamilton B Liu RE Parsons N Papadopoulos J Jen SM Powell AJ Krush T Berk Z Cohen B Tetu, et al. 1995 The molecular basis of Turcot's syndrome N Engl J Med 332 839 847 7661930 10.1056/NEJM199503303321302 1:CAS:528: DyaK2MXlt1eltrc%3D
33. MN Harris B Ozpolat F Abdi S Gu A Legler KG Mawuenyega M Tirado-Gomez G Lopez-Berestein X Chen 2004 Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia Blood 104 1314 1323 15142884 10.1182/blood-2004-01- 0046 1:CAS:528:DC%2BD2cXnt1eku7w%3D
34. TC He AB Sparks C Rago H Hermeking L Zawel LT da Costa PJ Morin B Vogelstein KW Kinzler 1998 Identification of c-MYC as a target of the APC pathway Science 281 1509 1512 9727977 10.1126/science.281.5382.1509 1:CAS:528:DyaK1cXlvFGntr0%3D
35. M Henriksson B Luscher 1996 Proteins of the Myc network: essential regulators of cell growth and differentiation Adv Cancer Res 68 109 182 8712067 10.1016/S0065-230X(08)60353-X 1:CAS:528:DyaK28Xktlegu7w%3D
36. S Heo G Lubec 2010 Generation and characterization of a specific polyclonal antibody against the mouse serotonin receptor 1A: a state-of-the-art recommendation on how to characterize antibody specificity Electrophoresis 31 3789 3796 21064142 10.1002/elps.201000374 1:CAS:528:DC%2BC3MXmsV2qsA%3D%3D
37. J Herms I Neidt B Luscher A Sommer P Schurmann T Schroder M Bergmann B Wilken S Probst-Cousin P Hernaiz-Driever J Behnke F Hanefeld T Pietsch HA Kretzschmar 2000 C-MYC expression in medulloblastoma and its prognostic value Int J Cancer 89 395 402 11008200 10.1002/1097-0215(20000920)89:5<395::AID- IJC1>3.0.CO;2-V 1:CAS:528:DC%2BD3cXnsFWmsro%3D
38. MN Hossain M Fuji K Miki M Endoh D Ayusawa 2007 Downregulation of hnRNP C1/C2 by siRNA sensitizes HeLa cells to various stresses Mol Cell Biochem 296 151 157 16960656 10.1007/s11010-006-9308-2 1:CAS:528:DC%2BD2sXjvFKis7w%3D
39. T Ide L Brown-Endres K Chu PP Ongusaha T Ohtsuka WS El-Deiry SA Aaronson SW Lee 2009 GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress Mol Cell 36 379 392 19917247 10.1016/j.molcel.2009.09.031 1:CAS:528:DC%2BD1MXhsFOlt7jP
40. A Jemal R Siegel E Ward Y Hao J Xu T Murray MJ Thun 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 18287387 10.3322/CA.2007.0010
41. K Jin XO Mao B Cottrell B Schilling L Xie RH Row Y Sun A Peel J Childs G Gendeh BW Gibson DA Greenberg 2004 Proteomic and immunochemical characterization of a role for stathmin in adult neurogenesis Faseb J 18 287 299 14769823 10.1096/fj.03-0973com 1:CAS:528:DC%2BD2cXht1Ggsbg%3D
42. JH Kim KY Paek K Choi TD Kim B Hahm KT Kim SK Jang 2003 Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner Mol Cell Biol 23 708 720 12509468 10.1128/MCB.23.2.708- 720.2003 1:CAS:528:DC%2BD3sXjslajtQ%3D%3D
43. DM Kokkinakis X Liu S Chada MM Ahmed MM Shareef UK Singha S Yang J Luo 2004 Modulation of gene expression in human central nervous system tumors under methionine deprivation-induced stress Cancer Res 64 7513 7525 15492278 10.1158/0008-5472.CAN-04-0592 1:CAS:528:DC%2BD2cXosFynurc%3D
44. A Korshunov A Benner M Remke P Lichter A von Deimling S Pfister 2008 Accumulation of genomic aberrations during clinical progression of medulloblastoma Acta Neuropathol 116 383 390 18704466 10.1007/s00401-008-0422-y 1:CAS:528:DC%2BD1cXhtV2jtL7L
45. Y Kouzu K Uzawa H Koike K Saito D Nakashima M Higo Y Endo A Kasamatsu M Shiiba H Bukawa H Yokoe H Tanzawa 2006 Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis Br J Cancer 94 717 723 16495930 1:CAS:528:DC%2BD28XitVyjtro%3D
46. MF Kuo HS Wang QT Kuo CT Shun HC Hsu SH Yang RH Yuan 2009 High expression of stathmin protein predicts a fulminant course in medulloblastoma J Neurosurg Pediatr 4 74 80 19569914 10.3171/2009.2.PEDS08287
47. J Liu D Levens 2006 Making myc Curr Top Microbiol Immunol 302 1 32 16620023 10.1007/3-540-32952-8-1 1:CAS:528:DC%2BD28XjsFOmtrw%3D
48. TJ MacDonald BR Rood MR Santi G Vezina K Bingaman PH Cogen RJ Packer 2003 Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors Oncologist 8 174 186 12697942 10.1634/theoncologist.8-2-174
49. JC MacLeod RJ Sayer JM Lucocq MJ Hubbard 2004 ERp29, a general endoplasmic reticulum marker, is highly expressed throughout the brain J Comp Neurol 477 29 42 15281078 10.1002/cne.20222 1:CAS:528:DC%2BD2cXnt1OntLk%3D
50. G Meffert FN Gellerich R Margreiter M Wyss 2005 Elevated creatine kinase activity in primary hepatocellular carcinoma BMC Gastroenterol 5 9 15748292 10.1186/1471-230X-5-9
51. RF Melhem XX Zhu N Hailat JR Strahler SM Hanash 1991 Characterization of the gene for a proliferation-related phosphoprotein (oncoprotein 18) expressed in high amounts in acute leukemia J Biol Chem 266 17747 17753 1917919 1:CAS:528:DyaK38XisV2ltLY%3D
52. SJ Mistry A Bank GF Atweh 2007 Synergistic antiangiogenic effects of stathmin inhibition and taxol exposure Mol Cancer Res 5 773 782 17670914 10.1158/1541-7786.MCR-06-0290 1:CAS:528:DC%2BD2sXptVWhsrw%3D
53. S Mkrtchian M Baryshev E Sargsyan I Chatzistamou AA Volakaki N Chaviaras A Pafiti A Triantafyllou H Kiaris 2008 ERp29, an endoplasmic reticulum secretion factor is involved in the growth of breast tumor xenografts Mol Carcinog 47 886 892 18395818 10.1002/mc.20444 1:CAS:528:DC%2BD1cXhtlOgtrbF
54. T Mori H Nagase A Horii Y Miyoshi T Shimano S Nakatsuru T Aoki H Arakawa A Yanagisawa Y Ushio, et al. 1994 Germ-line and somatic mutations of the APC gene in patients with Turcot syndrome and analysis of APC mutations in brain tumors Genes Chromosomes Cancer 9 168 172 7515658 10.1002/gcc.2870090304 1:CAS:528:DyaK2cXjt1Snsrs%3D
55. K Neben A Korshunov A Benner G Wrobel M Hahn F Kokocinski A Golanov S Joos P Lichter 2004 Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival Cancer Res 64 3103 3111 15126347 10.1158/0008-5472.CAN-03-3968 1:CAS:528: DC%2BD2cXjs1ehtrs%3D
56. CE Nesbit JM Tersak EV Prochownik 1999 MYC oncogenes and human neoplastic disease Oncogene 18 3004 3016 10378696 10.1038/sj.onc.1202746 1:CAS:528:DyaK1MXjs12qtLg%3D
57. TT Ngo T Peng XJ Liang O Akeju S Pastorino W Zhang Y Kotliarov JC Zenklusen HA Fine D Maric PY Wen U De Girolami PM Black WW Wu RF Shen NO Jeffries DW Kang JK Park 2007 The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas J Natl Cancer Inst 99 639 652 17440165 10.1093/jnci/djk135 1:CAS:528:DC%2BD2sXlvVSktr8%3D
58. AJ Obaya MK Mateyak JM Sedivy 1999 Mysterious liaisons: the relationship between c-Myc and the cell cycle Oncogene 18 2934 2941 10378690 10.1038/sj.onc.1202749 1:CAS:528:DyaK1MXjs12qtL4%3D
59. RJ Packer 2008 Childhood brain tumors: accomplishments and ongoing challenges J Child Neurol 23 1122 1127 18952578 10.1177/0883073808320758
60. S Pfister M Remke A Benner F Mendrzyk G Toedt J Felsberg A Wittmann F Devens NU Gerber S Joos A Kulozik G Reifenberger S Rutkowski OD Wiestler B Radlwimmer W Scheurlen P Lichter A Korshunov 2009 Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci J Clin Oncol 27 1627 1636 19255330 10.1200/JCO.2008.17.9432
61. GC Prendergast 1999 Mechanisms of apoptosis by c-Myc Oncogene 18 2967 2987 10378693 10.1038/sj.onc.1202727 1:CAS:528:DyaK1MXjs12qtL0%3D
62. J Radcliffe RJ Packer TE Atkins GR Bunin L Schut JW Goldwein LN Sutton 1992 Three- and four-year cognitive outcome in children with noncortical brain tumors treated with whole-brain radiotherapy Ann Neurol 32 551 554 1456739 10.1002/ana.410320411 1:STN:280:DyaK3s%2FovFyrtQ%3D%3D
63. A Ray M Ho J Ma RK Parkes TG Mainprize S Ueda J McLaughlin E Bouffet JT Rutka CE Hawkins 2004 A clinicobiological model predicting survival in medulloblastoma Clin Cancer Res 10 7613 7620 15569993 10.1158/1078-0432.CCR-04- 0499 1:CAS:528:DC%2BD2cXhtVanurzP
64. HA Rogers S Miller J Lowe MA Brundler B Coyle RG Grundy 2009 An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET) Br J Cancer 100 1292 1302 19293793 10.1038/sj.bjc.6604979 1:CAS:528:DC%2BD1MXksF2gtrk%3D
65. CI Rubin GF Atweh 2004 The role of stathmin in the regulation of the cell cycle J Cell Biochem 93 242 250 15368352 10.1002/jcb.20187 1:CAS:528: DC%2BD2cXotVyitbc%3D
66. S Rutkowski A von Bueren K von Hoff W Hartmann T Shalaby F Deinlein M Warmuth-Metz N Soerensen A Emser U Bode U Mittler C Urban M Benesch RD Kortmann PG Schlegel J Kuehl T Pietsch M Grotzer 2007 Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91 Clin Cancer Res 13 2651 2657 17473196 10.1158/1078-0432.CCR-06-1779 1:CAS:528:DC%2BD2sXkslOhtbg%3D
67. S Rutkowski NU Gerber K von Hoff A Gnekow U Bode N Graf F Berthold G Henze JE Wolff M Warmuth-Metz N Soerensen A Emser H Ottensmeier F Deinlein PG Schlegel RD Kortmann T Pietsch J Kuehl 2009 Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy Neuro Oncol 11 201 210 18818397 10.1215/15228517-2008-084 1:CAS:528: DC%2BD1MXkvFent78%3D
68. E Sargsyan M Baryshev L Szekely A Sharipo S Mkrtchian 2002 Identification of ERp29, an endoplasmic reticulum lumenal protein, as a new member of the thyroglobulin folding complex J Biol Chem 277 17009 17015 11884402 10.1074/jbc.M200539200 1:CAS:528:DC%2BD38XjslWhu74%3D
69. WG Scheurlen GC Schwabe S Joos J Mollenhauer N Sorensen J Kuhl 1998 Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome J Clin Oncol 16 2478 2485 9667267 1:STN:280:DyaK1czivFynsw%3D%3D
70. EV Schmidt 1999 The role of c-myc in cellular growth control Oncogene 18 2988 2996 10378694 10.1038/sj.onc.1202751 1:CAS:528:DyaK1MXjs12qtLo%3D
71. JH Silber J Radcliffe V Peckham G Perilongo P Kishnani M Fridman JW Goldwein AT Meadows 1992 Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score J Clin Oncol 10 1390 1396 1517781 1:STN:280:DyaK38zovV2mtQ%3D%3D
72. IM Siu A Lal JR Blankenship N Aldosari GJ Riggins 2003 c-Myc promoter activation in medulloblastoma Cancer Res 63 4773 4776 12941792 1:CAS:528:DC%2BD3sXms12gu7w%3D
73. A Spahn N Blondeau C Heurteaux F Dehghani A Rami 2008 Concomitant transitory up-regulation of X-linked inhibitor of apoptosis protein (XIAP) and the heterogeneous nuclear ribonucleoprotein C1-C2 in surviving cells during neuronal apoptosis Neurochem Res 33 1859 1868 18363099 10.1007/s11064-008-9658-0 1:CAS:528:DC%2BD1cXptVKgt7k%3D
74. D Stearns A Chaudhry TW Abel PC Burger CV Dang CG Eberhart 2006 c-myc overexpression causes anaplasia in medulloblastoma Cancer Res 66 673 681 16423996 10.1158/0008-5472.CAN-05-1580 1:CAS:528:DC%2BD28XlsFOltA%3D%3D
75. S Stockler PW Schutz GS Salomons 2007 Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology Subcell Biochem 46 149 166 18652076 10.1007/978-1-4020-6486-9-8
76. W Sun B Xing Y Sun X Du M Lu C Hao Z Lu W Mi S Wu H Wei X Gao Y Zhu Y Jiang X Qian F He 2007 Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues Mol Cell Proteomics 6 1798 1808 17627933 10.1074/mcp.M600449-MCP200 1:CAS:528:DC%2BD2sXht1WksbvM
77. M Takahashi XJ Yang TT Lavery KA Furge BO Williams M Tretiakova A Montag NJ Vogelzang GG Re AJ Garvin S Soderhall S Kagawa D Hazel-Martin A Nordenskjold BT Teh 2002 Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features Cancer Res 62 6598 6605 12438255 1:CAS:528:DC%2BD38XovFOks7o%3D
78. AO von Bueren T Shalaby J Rajtarova D Stearns CG Eberhart L Helson A Arcaro MA Grotzer 2007 Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells BMC Cancer 7 19 10.1186/1471-2407-7-19
79. AO von Bueren T Shalaby C Oehler-Janne L Arnold D Stearns CG Eberhart A Arcaro M Pruschy MA Grotzer 2009 RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells BMC Cancer 9 10 10.1186/1471-2407-9-10
80. K von Hoff B Hinkes NU Gerber F Deinlein U Mittler C Urban M Benesch M Warmuth-Metz N Soerensen I Zwiener H Goette PG Schlegel T Pietsch RD Kortmann J Kuehl S Rutkowski 2009 Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91 Eur J Cancer 45 1209 1217 10.1016/j.ejca.2009.01.015
81. K von Hoff W Hartmann AO von Bueren NU Gerber MA Grotzer T Pietsch S Rutkowski 2010 Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors Pediatr Blood Cancer 54 369 376 10.1002/pbc.22339
82. SH Wei F Lin X Wang P Gao HZ Zhang 2008 Prognostic significance of stathmin expression in correlation with metastasis and clinicopathological characteristics in human ovarian carcinoma Acta Histochem 110 59 65 18054374 10.1016/j.acthis.2007.06.002 1:CAS:528:DC%2BD1cXjt1Wgu7Y%3D
83. RH Yuan YM Jeng HL Chen PL Lai HW Pan FJ Hsieh CY Lin PH Lee HC Hsu 2006 Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma J Pathol 209 549 558 16739096 10.1002/path.2011 1:CAS:528:DC%2BD28XpsVarur0%3D
84. PM Zeltzer JM Boyett JL Finlay AL Albright LB Rorke JM Milstein JC Allen KR Stevens P Stanley H Li JH Wisoff JR Geyer P McGuire-Cullen JA Stehbens SB Shurin RJ Packer 1999 Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study J Clin Oncol 17 832 845 10071274 1:CAS:528:DyaK1MXhvFGgur0%3D
85. RH Zurawel SA Chiappa C Allen C Raffel 1998 Sporadic medulloblastomas contain oncogenic beta-catenin mutations Cancer Res 58 896 899 9500446 1:CAS:528:DyaK1cXhsFersr8%3D